Report Details

Estrogen Blockers Market

According to Intent Market Research, the Estrogen Blockers Market is expected to grow from USD 13.9 billion in 2023 at a CAGR of 6.8% to touch USD 22.1 billion by 2030. The Estrogen Blockers Market is dominated by key players such as AstraZeneca, Novartis, Pfizer, Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb, AbbVie Inc., Bayer AG, Amgen Inc., Ferring Pharmaceuticals, Sun Pharmaceutical Industries, Ipsen, Teva Pharmaceutical Industries, Mylan N.V.

Please state your requirements.


I have read the Terms & Conditions and Privacy Policy. I agree to its terms.

Get in touch

Location:

1846 E Innovation Park DR Site 100 ORO Valley AZ 85755

Call:

+1 463-583-2713